enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Oclacitinib, sold under the brand name Apoquel among others, is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. [1] [4] Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. [5]

3. Prescription drug prices in the United States - Wikipedia

   en.wikipedia.org/wiki/Prescription_drug_prices...

   Within the year of 2014, the cost of prescriptions had increased by at least 11.4% and 58% within the last eight years. The average cost for a month supply of brand-name drugs can run up to a couple of hundred US dollars, whereas in Canada and Great Britain the same medication could cost up to $40 US dollars.

4. Apoquel for Cats: Uses, Dosage, & Side Effects - AOL

   www.aol.com/lifestyle/apoquel-cats-uses-dosage...

   The FDA has not officially approved the use of Apoquel in cats. However, since its introduction to the market in 2013, the drug’s efficacy in cats has been subject to extensive study.

5. FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch ...

   www.aol.com/news/2013-05-16-fda-approves-apoquel...

   "The approval of APOQUEL provides a much-needed, new, targeted treatment choice for dogs that suffer from allergic skin conditions and affords the damaged skin an opportunity to heal, while ...

6. Health care prices in the United States - Wikipedia

   en.wikipedia.org/wiki/Health_care_prices_in_the...

   For example, the Kaiser Foundation reported that for the second-lowest cost "Silver plan" (a plan often selected and used as the benchmark for determining financial assistance), a 40-year old non-smoker making $30,000 per year would pay effectively the same amount in 2017 as they did in 2016 (about $208/month) after the subsidy/tax credit ...

7. Zoetis (ZTS) Q2 2024 Earnings Call Transcript - AOL

   www.aol.com/zoetis-zts-q2-2024-earnings...

   Our key dermatology franchise exemplifies this commitment, delivering strong 18% operational growth driven by Apoquel and Apoquel chewable along with Cytopoint, we have transformed the management ...